First-in-Class PAM Targetting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Research unit

INNOSUISSE

Project number

121.127 IP-LS

Project title

First-in-Class PAM Targeting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Project status	In Process

Start date	01.06.2025
End date	30.11.2026

Granted total costs	574'040.90 CHF
Section	60 Life Sciences
Project category	Project
Research type	Applied research and development
NABS classification	Industrial production and technology

Research disciplines	100 % T410 Pharmaceuticals and related technologies

Last modification of the project